Navigation Links
Emotient Gains Exclusive Rights to New, Expansive Patent Issued for Automated Facial Action Coding System
Date:9/3/2014

SAN DIEGO, Sept. 3, 2014 /PRNewswire/ -- Emotient, the leading provider of facial expression measurement data and analysis, today announced exclusive rights to a newly issued patent (US 8,798,374 B2) entitled, "Automated Facial Action Coding System." This expansive patent protects Emotient's core technology, from face detection to measurement of primary emotions, to detection of facial muscle movements.

"We believe the automated facial action coding patent is very expansive and protects much of our core system," said Ken Denman, President and CEO, Emotient. "We remain committed to growing our intellectual property portfolio. Over the last 18 months, we have filed 16 patent applications to protect additional aspects of our core technology, as well as innovative vertical applications for the retail, health-care, education, and entertainment industries."

The automated facial action coding patent inventors include Emotient Co-Founders Dr. Marian Bartlett, Dr. Gwen Littlefort, Dr. Javier Movellan, Dr. Ian Fasel and their colleague Mark Frank from University of New York. The patent was issued to the Regents of the University of California and The Research Foundation of State University of New York on August 5, 2014. Emotient holds exclusive rights to this and other work that the team developed while at UC San Diego, prior to leaving and co-founding Emotient in 2012. The patent covers the system and method to detect faces and facial features, machine learning techniques for feature selection that are trained on spontaneous expressions; deep neural network applications to machine learning-based classifiers trained on spontaneous expressions and determination of the presence of one or more elementary facial muscle movements or Action Units (AUs).

Emotient is focused on delivering its video-based expression measurement and sentiment analysis software to Global 2000 customers in the market research, retail, education and healthcare verticals. Emotient's software enables businesses to deliver better products, enhance the user experience, and improve patient care. Emotient provides access to critical emotion insights, processing anonymous facial expressions of individuals and groups; the software does not store video or images.  Emotient detects and measures seven facial expressions of primary emotion (joy, surprise, sadness, anger, fear, disgust and contempt); overall sentiments (positive, negative, and neutral), advanced emotions (frustration and confusion) and 19 Action Units (AUs). The Emotient system sets the industry standard for accuracy, with the precise ability to detect single-frame microexpressions of emotions. 

About Emotient – Automated Facial Expression Analysis
(www.emotient.com)
Emotient, Inc., is the leading authority in facial expression analysis. Emotient's software translates facial expressions into actionable information, thereby enabling companies to develop emotion-aware technologies and to create new levels of customer engagement, research, and analysis. For more information on Emotient, please visit www.emotient.com.


'/>"/>
SOURCE Emotient
Copyright©2014 PR Newswire.
All rights reserved

Related biology news :

1. Emotient and iMotions Partner to Offer Unique Integrated Facial Expression Recognition, Bio Sensor and Eye Tracking Solution for Usability, Gaming, Market and Academic/ Scientific Research
2. Green tea polyphenols protect spinal cord neurons against oxidative stress
3. New vaccine shows promise as stronger weapon against both tuberculosis and leprosy
4. Texas Biomed gains $2.7 million NIH grant to research genetic basis of diseases
5. Pinpointing genes that protect against frailty
6. A website to help safeguard the United States borders against alien scale insect pests
7. Atorvastatin protects against cerebral ischemia/reperfusion injury
8. Dissolvable fabric loaded with medicine might offer faster protection against HIV
9. Healthy lifestyle may buffer against stress-related cell aging, study says
10. New drug target can break down cancers barrier against treatment
11. SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against Provectus Biopharmaceuticals, Inc. and Certain Officers - PVCT
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2016)... , Dec. 15, 2016   WaferGen Bio-systems, Inc. ... genomics technology company, announced today that on December 13, ... Department of The Nasdaq Stock Market LLC which acknowledged ... price of WaferGen,s common stock had been at $1.00 ... has regained compliance with Listing Rule 5550(a)(2) of the ...
(Date:12/12/2016)... -- Researchers at Trinity College, Dublin, are opening up ... material with Silly Putty. The mixture (known as "G-putty") ... sense pulse, blood pressure, respiration, and even the ... The research team,s findings were published Thursday in ... Due ...
(Date:12/7/2016)... Avanade is helping Williams Martini Racing, one of ... biometric data in order to critically analyse every aspect ... against their rivals after their impressive, record-breaking pit stop ... with Williams during the 2016 season to capture and ... rate, temperature and peak acceleration) for key members of ...
Breaking Biology News(10 mins):
(Date:1/19/2017)... , Jan. 19, 2017 AquaBounty Technologies, Inc. ... enhancing productivity in aquaculture and a majority-owned subsidiary of ... it has completed the listing of its common shares ... subscription from Intrexon. "AquaBounty,s listing on NASDAQ ... broaden our exposure to the U.S. markets as we ...
(Date:1/19/2017)... ... 18, 2017 , ... LabRoots , the leading provider ... world, was today awarded the "Best Science & Technology Social Networking Service 2016" ... decided upon by a dedicated team of researchers and analysts. , The 2016 ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... spanning the full spectrum of drug and device development, and Prism Clinical ... companies and clinicians, today announced Verified Clinical Trials (VCT) has been ...
(Date:1/19/2017)... Jan. 18, 2017  Northwest Biotherapeutics, Inc. (OTCQB: NWBO) ... immune therapies for operable and inoperable solid tumor cancers, ... Technical Officer of NW Bio, will present at the ... at the Hyatt Regency Hotel in Miami, ... the session entitled "New Therapeutic Approaches – Expanding the ...
Breaking Biology Technology: